1. Home
  2. SINT vs NERV Comparison

SINT vs NERV Comparison

Compare SINT & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$4.14

Market Cap

15.0M

Sector

Health Care

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$3.93

Market Cap

14.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
NERV
Founded
1996
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0M
14.6M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
SINT
NERV
Price
$4.14
$3.93
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$25.00
$4.00
AVG Volume (30 Days)
65.5K
93.1K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,270,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$80.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.71
$1.15
52 Week High
$7.36
$12.46

Technical Indicators

Market Signals
Indicator
SINT
NERV
Relative Strength Index (RSI) 61.64 56.31
Support Level $3.15 $3.76
Resistance Level $3.50 $4.42
Average True Range (ATR) 0.31 0.32
MACD 0.10 -0.06
Stochastic Oscillator 91.18 59.28

Price Performance

Historical Comparison
SINT
NERV

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Share on Social Networks: